Related Articles
Characterization of a prognostic four‑gene methylation signature associated with radiotherapy for head and neck squamous cell carcinoma
Experimental study of the anti-cancer mechanism of tanshinone IIA against human breast cancer
Tanshinone ⅡA participates in the treatment of endometriosis by regulating adhesion, invasion, angiogenesis and inhibition of PI3K/Akt/mTOR signaling pathway
Tanshinone IIA pretreatment attenuates ischemia/reperfusion-induced renal injury
SENP1 inhibits ferroptosis and promotes head and neck squamous cell carcinoma by regulating ACSL4 protein stability via SUMO1